Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
236.2 USD | +0.39% | +3.34% | +0.11% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.11% | 12.08B | |
+22.55% | 46.81B | |
-1.17% | 41.37B | |
+47.41% | 41.29B | |
-6.20% | 28.87B | |
+11.17% | 26.06B | |
-20.30% | 19.13B | |
+31.28% | 12.39B | |
-0.45% | 11.96B | |
+19.18% | 11.56B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Jefferies Lowers Price Target on Charles River Laboratories International to $203 From $233, Maintains Hold Rating